Hypertension in black patients: Special issues and considerations
- Shawna D. Nesbitt MD, MS
- … show all 1 hide
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The excess risk of hypertension in black Americans continues to be a major health concern. Although there is considerable information regarding these disease trends, much of the major underpinnings of the etiology of hypertension remain unclear. The excess mortality in blacks due to heart disease, renal failure, and stroke are clearly directly related to the excess burden of hypertension. Amid the recent findings about the pathophysiology of hypertension, some clear differences in the effects of overweight, salt sensitivity, and vascular biology emerge along ethnic lines. These differences may shed some light on the development of more effective treatment strategies. Based on our current knowledge, aggressive management of hypertension in blacks is critical. This review highlights what is known about various factors affecting hypertension and its treatment in black Americans.
- Cappuccio FP, Micah FB, Emmett L, et al.: Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension 2004, 43:1017–1022. CrossRef
- Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003, 290:199–206. CrossRef
- Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995, 25:305–313.
- Flack JM, Ferdinand KC, Nasser SA: Epidemiology of hypertension and cardiovascular disease in African Americans. J Clin Hypertens (Greenwich) 2003, 5(1 Suppl 1):5–11. This article describes the disparity in the epidemiology of hypertension and target organ disease and is a current review of hypertension in black Americans. CrossRef
- Flack JM, Peters R, Mehra VC, Nasser SA: Hypertension in special populations. Cardiol Clin 2002, 20:303–319. CrossRef
- Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996, 27(3 Pt 2):481–490.
- Luft FC, Grim CE, Higgins JT Jr., Weinberger MH: Differences in response to sodium administration in normotensive white and black subjects. J Lab Clin Med 1977, 90:555–562.
- Sullivan JM, Prewitt RL, Ratts TE: Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med Sci 1988, 295:370–377. CrossRef
- Madhavan S, Alderman MH: Ethnicity and the relationship of sodium intake to blood pressure. J Hypertens 1994, 12:97–103. CrossRef
- He FJ, Markandu ND, Sagnella GA, MacGregor GA: Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension 1998, 32:820–824.
- Wilson TW, Grim CE: Biohistory of slavery and blood pressure differences in blacks today. A hypothesis. Hypertension 1991, 17(1 Suppl):I122-I128.
- Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002, 288(14):1723–1727. CrossRef
- Mokdad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76–79. CrossRef
- Cooper RS, Kaufman JS: Race and hypertension: science and nescience. Hypertension 1998, 32:813–816.
- Gillum RF, Mussolino ME, Madans JH: Body fat distribution and hypertension incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Int J Obes Relat Metab Disord 1998, 22:127–134. CrossRef
- Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998, 22:39–47. CrossRef
- Hahn RA, Heath GW, Chang MH: Cardiovascular disease risk factors and preventive practices among adults--United States, 1994: a behavioral risk factor atlas. Behavioral Risk Factor Surveillance System State Coordinators. MMWR CDC Surveill Summ 1998, 47:35–69.
- Haffner SM, Ferrannini E, Hazuda HP, Stern MP: Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992, 20:38–45.
- Saad MF, Lillioja S, Nyomba BL, et al.: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991, 324:733–739. CrossRef
- Manolio TA, Savage PJ, Burke GL, et al.: Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 1990, 10:430–436.
- Park YW, Zhu S, Palaniappan L, et al.: The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003, 163:427–436. CrossRef
- Appel LJ, Champagne CM, Harsha DW, et al., for the Writing Group of the PREMIER Collaborative Research Group: Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 2003, 289:2083–2093. CrossRef
- Julius S, Valentini M, Palatini P: Overweight and hypertension: a 2-way street? Hypertension 2000, 35:807–813.
- Levine JA, Eberhardt NL, Jensen MD: Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999, 283:212–214. CrossRef
- Weyer C, Pratley RE, Snitker S, et al.: Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 2000, 36:531–537.
- Abate NI, Mansour YH, Tuncel M, et al.: Overweight and sympathetic overactivity in black Americans. Hypertension 2001, 38:379–383.
- Nesbitt S, Victor RG: Pathogenesis of hypertension in African Americans. Congest Heart Fail 2004, 10:24–29. This is a review of current findings relating to the pathogenesis of hypertension in black Americans. CrossRef
- Luke A, Adeyemo A, Kramer H, et al.: Association between blood pressure and resting energy expenditure independent of body size. Hypertension 2004, 43:555–560. CrossRef
- Anderson NB, Mcneilly M: Autonomic reactivity and hypertension in blacks: toward a contextual model. In Pathophysiology of Hypertension in Blacks. Edited by Fray JCS, Douglas JG. New York: Oxford Press; 1993.
- Grubbs AL, Ergul A: A review of endothelin and hypertension in African American individuals. Ethn Dis 2001, 11:741–748.
- Vita JA: Nitric oxide and vascular reactivity in African American patients with hypertension. J Cardiac Failure 2003, 9:S199-S204. CrossRef
- Hypertension Detection and Follow-up Program Cooperative Group: Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Followup Program. JAMA 1988, 259:2113–2122. CrossRef
- Wright JT Jr, Bakris G, Greene T, et al., for the African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial. JAMA 2002, 288:2421–2431. This is a recent large clinical trial of blacks with hypertension and kidney disease assessing blood pressure control and various drug therapies. CrossRef
- Din-Dzietham R, Nembhard WN, Collins R, Davis SK: Perceived stress following race-based discrimination at work is associated with hypertension in African-Americans. The metro Atlanta heart disease study, 1999–2001. Soc Sci Med 2004, 58:449–461. CrossRef
- Steffen PR, McNeilly M, Anderson N, Sherwood A: Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med 2003, 65:746–750. CrossRef
- Gornick ME, Eggers PW, Reilly TW, et al.: Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996, 335:791–799. CrossRef
- Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252. CrossRef
- Douglas JG, Bakris GL, Epstein M, et al., for the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks: Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003, 163:525–541. This is a consensus statement from leading experts in hypertension providing evidence-based guidelines for treatment paradigms specific to blacks. CrossRef
- Joint National Committee: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413–2446. CrossRef
- Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999, 17:151–183.
- Schwartz RS: Racial profiling in medical research. N Engl J Med 2001, 344:1392–1393. CrossRef
- Flack JM, Mensah GA, Ferrario CM: Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage. Curr Med Res Opin 2000, 16:66–79. CrossRef
- Jamerson KA: Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. Am J Kidney Dis 2000, 36(3 Suppl 1):S24-S30.
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2997. This is a large clinical trial including a significant number of black Americans performed in the community with multiple drug therapies, providing insight into drug responses and mortality outcomes. CrossRef
- He J, Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999, 138(3 Pt 2):211–219. CrossRef
- Richardson AD, Piepho RW: Effect of race on hypertension and antihypertensive therapy. Int J Clin Pharmacol Ther 2000, 38:75–79.
- Cushman WC, Reda DJ, Perry HM, et al.: Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 2000, 160:825–831. CrossRef
- Saunders E, Weir MR, Kong BW, et al.: A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990, 150:1707–1713. CrossRef
- Materson BJ, Reda DJ, Williams D: Lessons from combination therapy in Veterans Affairs Studies. Department of Veterans Affairs Cooperative Study Group on antihypertensive agents. Am J Hypertens 1996, 9(12 Pt 2):187S-191S. CrossRef
- Yancy CW, Fowler MB, Colucci WS, et al., Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001, 344:1358–1365. CrossRef
- Julius S, Alderman MH, Beevers G, et al.: Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol 2004, 43:1047–1055. CrossRef
- Hypertension in black patients: Special issues and considerations
Current Cardiology Reports
Volume 6, Issue 6 , pp 416-420
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Author Affiliations
- 1. The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, 75390-8899, Dallas, TX, USA